Serum Biomarkers for Traumatic Brain Injury

被引：29
|
作者：
Neher, Miriam D.
Keene, Chesleigh N.
Rich, Megan C.
Moore, Hunter B.
Stahel, Philip F. [1 ]
机构：
[1] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Denver, CO 80204 USA
来源：
SOUTHERN MEDICAL JOURNAL | 2014年 / 107卷 / 04期
关键词：
astroglial injury; axonal injury; biomarkers; neuronal injury; outcome prediction; risk stratification; traumatic brain injury; NEURON-SPECIFIC-ENOLASE; FIBRILLARY ACIDIC PROTEIN; MILD HEAD-INJURY; C-TERMINAL HYDROLASE; MYELIN BASIC-PROTEIN; CEREBROSPINAL-FLUID; BIOCHEMICAL MARKERS; ELEVATED LEVELS; S-100B PROTEIN; INTRACRANIAL LESIONS;
D O I：
10.1097/SMJ.0000000000000086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There is a lack of reliable serum biomarkers for routine use in the diagnostic workup of people with traumatic brain injury. Multiple biomediators and biomarkers have been described in the pertinent literature in recent years; however, only a few candidate molecules have been associated with high sensitivity and high specificity for risk stratification and outcome prediction after traumatic brain injury. This review was designed to provide an overview of the state of the art regarding established serum biomarkers in the field and to outline future directions of investigation.
引用
收藏
页码：248 / 255
页数：8
相关论文
共 50 条
  • [31] The Clinical Use of Serum Biomarkers in Traumatic Brain Injury: A Systematic Review Stratified by Injury Severity
    Al-Adli, Nadeem
    Akbik, Omar S.
    Rail, Benjamin
    Montgomery, Eric
    Caldwell, Christie
    Barrie, Umaru
    Vira, Shaleen
    Al Tamimi, Mazin
    Bagley, Carlos A.
    Aoun, Salah G.
    WORLD NEUROSURGERY, 2021, 155 : E418 - E438
  • [32] BRAIN SPECIFIC MICRORNA BIOMARKERS IN SERUM AND CEREBROSPINAL FLUID AND CORRELATION WITH OUTCOME OF TRAUMATIC BRAIN INJURY
    Bhomia, Manish
    Gayen, Manoshi
    Li, Zhaozhang
    Wang, Kevin K. W.
    Knollmann-Ritschel, Barbara
    JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A122 - A122
  • [33] DIFFERENT PROFILES OF CSF AND SERUM BIOMARKERS OF CNS INJURY IN PRECLINICAL MODELS OF TRAUMATIC BRAIN INJURY AND NEUROTOXICITY
    Glushakova, Olena
    Johnson, Danny
    Denslow, Nancy
    Hayes, Ronald L.
    JOURNAL OF NEUROTRAUMA, 2013, 30 (15) : A130 - A131
  • [34] Serum biomarkers and disease progression in CT-negative mild traumatic brain injury
    Jia, Xiaoyan
    Li, Xuan
    Ji, Qiuyu
    Yin, Bo
    Pan, Yizhen
    Zhao, Wenpu
    Bai, Guanghui
    Zhang, Jie
    Bai, Lijun
    CEREBRAL CORTEX, 2024, 34 (01)
  • [35] The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children
    Berger, Rachel Pardes
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2006, 21 (04) : 315 - 333
  • [36] A Panel of Serum MiRNA Biomarkers for the Diagnosis of Severe to Mild Traumatic Brain Injury in Humans
    Manish Bhomia
    Nagaraja S. Balakathiresan
    Kevin K. Wang
    Linda Papa
    Radha K. Maheshwari
    Scientific Reports, 6
  • [37] CLINICAL STUDIES OF THE UTILITY OF SERUM BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS, AND MANAGEMENT OF TRAUMATIC BRAIN INJURY
    Hayes, Ronald
    Mondello, Stefania
    Wang, Kevin
    JOURNAL OF NEUROTRAUMA, 2011, 28 (05) : A24 - A24
  • [38] USE OF SERUM BIOMARKERS TO PREDICT CEREBRAL HYPOPERFUSION FOLLOWING SEVERE TRAUMATIC BRAIN INJURY
    Stein, Deborah
    Lindell, Allison
    Murdock, Karen
    Kufera, Joseph
    Menaker, Jay
    Bochicchio, Grant
    Aarabi, Bizhan
    Scalea, Thomas
    JOURNAL OF NEUROTRAUMA, 2011, 28 (06) : A92 - A93
  • [39] ROLE OF SERUM BIOMARKERS IN INDIVIDUALS IN COMA OR VEGETATIVE STATE AFTER TRAUMATIC BRAIN INJURY
    Mondello, Stefania
    Gabrielli, Andrea
    Catani, Sheila
    D'Ippolito, Mariagrazia
    Tortella, Frank
    Schmidt, Kara
    Hayes, Ronald L.
    Wang, Kevin K.
    Formisano, Rita
    JOURNAL OF NEUROTRAUMA, 2011, 28 (05) : A8 - A8
  • [40] USE OF SERUM BIOMARKERS TO PREDICT SECONDARY INSULTS FOLLOWING SEVERE TRAUMATIC BRAIN INJURY
    Stein, Deborah M.
    Lindel, Allison L.
    Murdock, Karen R.
    Kufera, Joseph A.
    Menaker, Jay
    Scalea, Thomas M.
    SHOCK, 2012, 37 (06): : 563 - 568
12345